BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6123142)

  • 1. In vitro effects of reproterol upon tracheo- bronchial, cardiac and cerebral adenylcyclase.
    Marmo E; DiMezza F; Giordano L; Scognamiglio M; Pentimalli D; Marfella A
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):389-95. PubMed ID: 6123142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacodynamic aspects of reproterol].
    Marmo E
    Clin Ter; 1981 Sep; 98(5):481-500. PubMed ID: 7307450
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of reproterol on ciliary beat frequency of human bronchial epithelium in vitro.
    Hesse H; Kasparek R; Mizera W; Unterholzner C; Konietzko N
    Arzneimittelforschung; 1981; 31(4):716-8. PubMed ID: 7195718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproterol--A monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma.
    Juergens UR; Stöber M; Vetter H
    Respiration; 1999; 66(3):220-4. PubMed ID: 10364737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clenbuterol on bronchial, cardiac and hypothalamic adenylate cyclase.
    Marmo E; Caputi AP; Nisticò GM; Rossi F; Lampa E
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):3-9. PubMed ID: 441515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation using dynamic ECG of the effects of reproterol (a new beta-2 adrenergic receptor agonist) on the heart conduction system].
    Citone C; Carelli M; Di Marcotullio G; Tubaro M; Milazzotto F
    Clin Ter; 1984 Sep; 110(5):429-36. PubMed ID: 6149836
    [No Abstract]   [Full Text] [Related]  

  • 7. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
    Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
    Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of purinergic system in tracheobronchial reactivity of healthy and bronchopathic subjects.
    Susanna V; Loffreda A; Matera MG; Servodio R; Filippelli A; Santagata A; Montanaro C; Carapella N; Marmo E
    Int J Tissue React; 1990; 12(1):59-65. PubMed ID: 2384299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of methacholine-induced bronchoconstriction with reproterol, a new beta agonist-xanthine derivative.
    Klaustermeyer WB; Kuhn GJ; Santiago SM; Wehiky I; Hunt EJ
    Ann Allergy; 1981 Apr; 46(4):189-92. PubMed ID: 7011112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of PaO2 after intravenous administration of reproterol in subjects with chronic obstructive bronchopneumopathy].
    Grandillo F; Giunta R; Grassia A; Cacciapuoti F; Nappo V; Varricchio M
    Arch Monaldi; 1983; 38(5-6):201-8. PubMed ID: 6437362
    [No Abstract]   [Full Text] [Related]  

  • 11. Reproterol and the muscle of the trachea and bronchi: in vitro and in vivo comparative studies with various drugs used in the treatment of asthma.
    Di Mezza F; Giordano L; Scognamiglio M; Montanaro A; Marmo E
    Respiration; 1981; 42(3):175-83. PubMed ID: 7313343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral salbutamol with reproterol in reversible airway obstruction.
    Dubey GR; Dabholkar SV; Kamat SR; Mahashur AA; Shah SP; Sonaje AG; Athawale SS
    J Assoc Physicians India; 1986 Mar; 34(3):179-82. PubMed ID: 3525508
    [No Abstract]   [Full Text] [Related]  

  • 13. [The hemodynamic effects of reproterol in patients with chronic obstructive lung disease (author's transl)].
    Bonaduce D; Ferrara N; Canonico V; Cocozza M; Petretta M; Romano E; Rengo F
    G Ital Cardiol; 1981; 11(10):1467-71. PubMed ID: 7341317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of reproterol in patients with obstructive pathology of the airways].
    Puzio E; Montanero F; Mosca L; Caserta L; Russo V
    Clin Ter; 1985 Jan; 112(2):141-4. PubMed ID: 3893858
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of antigen-induced bronchoconstriction with reproterol, a new beta agonist-xanthine derivative.
    Kuhn GJ; Weliky I; Santiago SM; Klaustermeyer WB
    Ann Allergy; 1981 Apr; 46(4):193-6. PubMed ID: 7011113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and in vivo performance of a novel freon-free metered dose inhaler for a fixed combinational product of reproterol and disodium cromoglycate.
    Hermann R; Ruus P; Schneider E; de Mey C
    Arzneimittelforschung; 1998 Jun; 48(6):663-7. PubMed ID: 9689424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic pretreatment with sympathomimetic bronchodilator drugs on the responsiveness of guinea-pig lung adenylate cyclase in vitro [proceedings].
    Elfellah MS; Marshall PB; Turnbull MJ
    Br J Pharmacol; 1976 Oct; 58(2):274P. PubMed ID: 974395
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Adrenergic receptors in heart muscle: similarity of apparent affinities of beta-blockers for receptors mediating adenyl-cyclase activity, inotropic and chronotropic effects of catecholamines.
    Kaumann AJ; Birnbaumer L
    Acta Physiol Lat Am; 1973; 23(6):619-20. PubMed ID: 4153011
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect and tolerance of intravenous reproterol in infants and children].
    Camprag D; Dovat V; Bogdanov B; Conkić B; Tabori D; Aurich R
    Med Welt; 1979 Jun; 30(23):897-901. PubMed ID: 459809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.